We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTCH
12151
PUT
DELISTED
Latch, Inc. Common Stock
LTCH
$29K ﹤0.01%
25,000
+11,500
+85% +$29.4K
WTT
12152
CALL
DELISTED
Wireless Telecom Group, Inc.
WTT
$29K ﹤0.01%
+21,900
New +$32.9K
ADIL
12153
CALL
Adial Pharmaceuticals
ADIL
$10.5M
$28K ﹤0.01%
+34
New +$30.8K
BBAI.WS icon
12154
BigBear.ai Holdings Warrant
BBAI.WS
$38.5M
$28K ﹤0.01%
70,247
-18,432
-21% -$14.6K
BTOG icon
12155
Bit Origin
BTOG
$3.41M
$28K ﹤0.01%
+36
New +$51.5K
BWEN icon
12156
PUT
Broadwind
BWEN
$127M
$28K ﹤0.01%
16,800
-25,800
-61% -$46.2K
CDTX
12157
DELISTED
Cidara Therapeutics
CDTX
$28K ﹤0.01%
+2,868
New +$35.4K
CLRB icon
12158
Cellectar Biosciences
CLRB
$24.6M
$28K ﹤0.01%
+230
New +$32.9K
DRTSW icon
12159
Alpha Tau Medical Warrant
DRTSW
$87.6M
$28K ﹤0.01%
54,582
+396
+0.7% +$221
IRON icon
12160
PUT
Disc Medicine
IRON
$3.03B
$28K ﹤0.01%
+553
New +$24.5K
MFG icon
12161
PUT
Mizuho Financial
MFG
$132B
$28K ﹤0.01%
12,300
-700
-5% -$1.65K
PLG
12162
Platinum Group Metals
PLG
$189M
$28K ﹤0.01%
20,979
-138,266
-87% -$238K
PPBT
12163
Purple Biotech
PPBT
$2.44M
$28K ﹤0.01%
+60
New +$35.9K
QSI icon
12164
PUT
Quantum-Si Incorporated
QSI
$162M
$28K ﹤0.01%
12,000
-1,400
-10% -$5.36K
SCNI
12165
Scinai Immunotherapeutics
SCNI
$1.25M
$28K ﹤0.01%
238
-184
-44% -$25.3K
UROY
12166
CALL
Uranium Royalty Corp
UROY
$1.57B
$28K ﹤0.01%
+12,200
New +$39.1K
VTVT icon
12167
vTv Therapeutics
VTVT
$119M
$28K ﹤0.01%
+932
New +$23.9K
VVOS icon
12168
CALL
Vivos Therapeutics
VVOS
$4.77M
$28K ﹤0.01%
856
+4
+0.5% +$166
PHLT
12169
PUT
DELISTED
Performant Healthcare Inc
PHLT
$28K ﹤0.01%
10,700
-200
-2% -$496
RNLX
12170
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$28K ﹤0.01%
11,600
ACER
12171
DELISTED
Acer Therapeutics Inc
ACER
$28K ﹤0.01%
+22,574
New +$47.3K
EXN
12172
DELISTED
Excellon Resources Inc.
EXN
$28K ﹤0.01%
+62,000
New +$39K
CIG icon
12173
PUT
CEMIG Preferred Shares
CIG
$5.52B
$27K ﹤0.01%
+17,316
New +$30.3K
CTMX icon
12174
CALL
CytomX Therapeutics
CTMX
$732M
$27K ﹤0.01%
14,700
-1,900
-11% -$3.64K
LAB icon
12175
PUT
Standard BioTools
LAB
$280M
$27K ﹤0.01%
17,100
-3,400
-17% -$8.41K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.